参考文献/References:
[1] CHANDRAN M,BRIND'AMOUR K,FUJIWARA S,et al.Prevalence of osteoporosis and incidence of related fractures in developed economies in the Asia Pacific Region:a systematic review[J].Osteoporos Int,2023,34(6):1037-1053.
[2] TALEVSKI J,SANDERS K M,BUSIJA L,et al.Health ser-vice use and quality of life recovery 12 months following major osteoporotic fracture:latent class analyses of the International Costs and Utilities Related to Osteoporotic Fractures Study(ICUROS)[J].J Bone Miner Res,2021,36(2):252-261.
[3] ZHANG J,HE X,FAN Y,et al.Risk factors for conservative treatment failure in acute osteoporotic vertebral compression fractures(OVCFs)[J].Arch Osteoporos,2019,14(1):24.
[4] LEE B G,CHOI J H,KIM D Y,et al.Risk factors for newly developed osteoporotic vertebral compression fractures following treatment for osteoporotic vertebral compression fractures[J].Spine J,2019,19(2):301-305.
[5] ROBINSON W A,CARLSON B C,POPPENDECK H,et al.Osteoporosis-related vertebral fragility fractures:a review and analysis of the American Orthopaedic Association's Own the Bone Database[J].Spine(Phila Pa 1976),2020,45(8):E430-E438.
[6] HINDE K,MAINGARD J,HIRSCH J A,et al.Mortality outcomes of vertebral augmentation(vertebroplasty and/or balloon kyphoplasty)for osteoporotic vertebral compression fractures:a systematic review and Meta-analysis[J].Radiology,2020,295(1):96-103.
中医正骨2023年7月第35卷第7期 J Trad Chin Orthop Trauma,2023,Vol.35,No.7(总519)
(总520)中医正骨2023年7月第35卷第7期 J Trad Chin Orthop Trauma,2023,Vol.35,No.7
[7] LÁINEZ RAMOS-BOSSINI A J,LÓPEZ ZUÑIGA D,RUIZ SANTIAGO F.Percutaneous vertebroplasty versus conservative treatment and placebo in osteoporotic vertebral fractures:meta-analysis and critical review of the literature[J].Eur Radiol,2021,31(11):8542-8553.
[8] HOYT D,URITS I,ORHURHU V,et al.Current concepts in the management of vertebral compression fractures[J].Curr Pain Headache Rep,2020,24(5):16.
[9] YANG W,SONG J,LIANG M,et al.Functional outcomes and new vertebral fractures in percutaneous vertebroplasty and conservative treatment of acute symptomatic osteoporotic vertebral compression fractures[J].World Neurosurg,2019,131:e346-e352.
[10] YAMADA Y,TORIBATAKE Y,OKAMOTO S,et al.Recompression of augmented vertebrae after balloon kyphoplasty is a risk of adjacent vertebral fracture[J].Spine Surg Relat Res,2023,7(1):89-95.
[11] CHOI S S,KIM H,CHOUNG Y J,et al.Risk factors for new vertebral compression fracture after kyphoplasty and efficacy of osteoporosis treatment:a STROBE-compliant retrospective study[J].Medicine(Baltimore),2022,101(49):e32018.
[12] CHENG Y,CHENG X,WU H.Risk factors of new vertebral compression fracture after percutaneous vertebroplasty or percutaneous kyphoplasty[J].Front Endocrinol(Lausanne),2022,13:964578.
[13] ZOHRA A,GONLUGUR U.Cement pulmonary embolism due to percutaneous vertebroplasty[J].Curr Med Imaging,2021,17(4):559-561.
[14] VOORMOLEN M H,MALI W P,LOHLE P N,et al.Percutaneous vertebroplasty compared with optimal pain medication treatment:short-term clinical outcome of patients with subacute or chronic painful osteoporotic vertebral compression fractures.The VERTOS study[J].AJNR Am J Neuroradiol,2007,28(3):555-560.
[15] ROUSING R,ANDERSEN M O,JESPERSEN S M,et al.Percutaneous vertebroplasty compared to conservative treatment in patients with painful acute or subacute osteoporotic vertebral fractures:three-months follow-up in a clinical randomized study[J].Spine(Phila Pa 1976),2009,34(13):1349-1354.
[16] KLAZEN C A,LOHLE P N,DE VRIES J,et al.Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures(VertosII):an open-label randomised trial[J].Lancet,2010,376(9746):1085-1092.
[17] FARROKHI M R,ALIBAI E,MAGHAMI Z.Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures[J].J Neurosurg Spine,2011,14(5):561-569.
[18] BLASCO J,MARTINEZ-FERRER A,MACHO J,et al.Effect of vertebroplasty on pain relief,quality of life,and the incidence of new vertebral fractures:a 12-month randomized follow-up,controlled trial[J].J Bone Miner Res,2012,27(5):1159-1166.
[19] CHEN D,AN Z Q,SONG S,et al.Percutaneous vertebroplasty compared with conservative treatment in patients with chronic painful osteoporotic spinal fractures[J].J Clin Neurosci,2014,21(3):473-477.
[20] YANG E Z,XU J G,HUANG G Z,et al.Percutaneous vertebroplasty versus conservative treatment in aged patients with acute osteoporotic vertebral compression fractures:a prospective randomized controlled clinical study[J].Spine(Phila Pa 1976),2016,41(8):653-660.
[21] 冯智峰,饶东,肖思贤.经皮椎体成形术治疗骨质疏松性椎体压缩性骨折的效果分析[J].中外医疗,2021,40(25):40-42.
[22] LONGO U G,PAPALIA R,DENARO L,et al.Trends in hospitalization and economic impact of percutaneous kyphoplasty in Italy[J].J Clin Med,2022,11(24):7464.
[23] BUCHBINDER R,GOLMOHAMMADI K,JOHNSTON R V,et al.Percutaneous vertebroplasty for osteoporotic vertebral compression fracture[J].Cochrane Database Syst Rev,2015(4):CD006349.
[24] KOBAYASHI K,SHIMOYAMA K,NAKAMURA K,et al.Percutaneous vertebroplasty immediately relieves pain of osteoporotic vertebral compression fractures and prevents prolonged immobilization of patients[J].Eur Radiol,2005,15(2):360-367.
[25] FARROKHI M R,ALIBAI E,MAGHAMI Z.Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures[J].J Neurosurg Spine,2011,14(5):561-569.
[26] 边树愿,郭涛.骨质疏松性椎体压缩骨折经皮椎体强化术后椎体高度再丢失的研究进展[J].中国脊柱脊髓杂志,2018,28(7):663-666.
[27] AN Z,CHEN C,WANG J,et al.Logistic regression analysis on risk factors of augmented vertebra recompression after percutaneous vertebral augmentation[J].J Orthop Surg Res,2021,16(1):374.
[28] PATEL N,JACOBS D,JOHN J,et al.Balloon kyphoplasty vs vertebroplasty:a systematic review of height restoration in osteoporotic vertebral compression fractures[J].J Pain Res,2022,15:1233-1245.
[29] DAHER M,KREICHATI G,KHARRAT K,et al.Vertebroplasty versus kyphoplasty in the treatment of osteoporotic vertebral compression fractures:a meta-analysis[J].World Neurosurg,2023,171:65-71.
[30] IIDA K,HARIMAYA K,TARUKADO K,et al.Kyphosis progression after balloon kyphoplasty compared with conservative treatment[J].Asian Spine J,2019,13(6):928-935.
[31] LIN S,CAI X,CHENG Q,et al.Association between bone turnover markers,BMD and height loss of cemented vertebrae after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures[J].J Orthop Surg Res,2022,17(1):202.
[32] PIAZZOLLA A,BIZZOCA D,SOLARINO G,et al.Vertebral fragility fractures: clinical and radiological results of augmentation and fixation—a systematic review of randomized controlled clinical trials[J].Aging Clin Exp Res,2020,32(7):1219-1232.
相似文献/References:
[1]张亮,张莉,王莉佳,等.快速康复外科理念在椎弓根螺钉内固定治疗
胸腰椎骨折围手术期护理中的应用[J].中医正骨,2015,27(06):75.
[2]潘雄,刘其顺,应行,等.中药联合4步康复锻炼法对骨质疏松性椎体压缩
骨折患者生存质量的影响[J].中医正骨,2015,27(04):65.
[3]宋永枝,陈双玲.唑来膦酸静脉滴注联合鲑降钙素肌肉注射治疗
骨质疏松性长骨骨折[J].中医正骨,2016,28(01):70.
[4]孙兰芬,王龙强,刘润宏,等.颈椎骨折脱位合并脊髓损伤截瘫患者的围手术期护理[J].中医正骨,2016,28(03):79.
[5]吴鹏,王博,孔令成,等.强骨饮颗粒联合阿仑膦酸钠维D3片口服在原发性骨质疏松性髋部骨折术后抗骨质疏松治疗中的应用[J].中医正骨,2016,28(05):16.
WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(强骨饮颗粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(07):16.
[6]梅 伟.胸腰椎骨折临床诊疗中的热点问题[J].中医正骨,2016,28(07):1.
[7]徐无忌,刘晓岚.体位复位结合经皮椎体成形术与经皮椎体后凸成形术治疗骨质疏松性椎体压缩骨折的对比研究[J].中医正骨,2016,28(07):20.
XU Wuji,LIU Xiaolan.Effect of Qianggu Yin(强骨饮,QGY)on bone microstructure in the ovariectomized osteoporosis rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(07):20.
[8]李英周,叶锋,王晓,等.后路撬拨植骨椎弓根螺钉内固定治疗胸腰椎骨折[J].中医正骨,2016,28(07):46.
[9]王军,陈哲,王硕凡.胸腰椎骨折椎体植骨材料的临床应用进展[J].中医正骨,2016,28(07):64.
[10]史晓林,王健,王博,等.脆性骨折的防治进展[J].中医正骨,2017,29(05):20.
[11]陈建德,樊晓琦,夏炳江,等.球囊扩张部位对椎体后凸成形术治疗骨质疏松性椎体压缩骨折疗效及安全性的影响[J].中医正骨,2017,29(02):11.
CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(07):11.
[12]丁志清,颜峰,喻灿明,等.椎体后凸成形术后非典型骨水泥植入综合征死亡1例[J].中医正骨,2017,29(11):76.
[13]俞兴,王婷,杨济洲,等.经皮椎体成形术和经皮椎体后凸成形术治疗Kmmell病的对比研究[J].中医正骨,2018,30(06):23.
YU Xing,WANG Ting,YANG Jizhou,et al.A retrospective trial of percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of Kmmell's diseases[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(07):23.
[14]彭小东,张晓刚,赵文韬,等.有限元分析在过伸复位治疗骨质疏松性椎体压缩性骨折生物力学研究中的应用进展[J].中医正骨,2018,30(07):25.
[15]陈建德,樊晓琦,凌义龙.单侧椎弓根旁外侧入路与双侧椎弓根入路
经皮椎体后凸成形术治疗骨质疏松性胸椎
压缩性骨折的对比研究[J].中医正骨,2018,30(10):19.
CHEN Jiande,FAN Xiaoqi,LING Yilong.A retrospective trial of percutaneous kyphoplasty through unilateral extrapedicular approach versus bilateral transpedicular approach for treatment of thoracic osteoporotic vertebral compression fracture[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(07):19.
[16]于东方,王祥善,张华,等.经皮椎体成形术后手术椎体再骨折的病因、治疗及预防[J].中医正骨,2018,30(10):69.
[17]李兆勇,杨少锋,张晨阳.补肾活血方联合经皮椎体强化术治疗骨质疏松性椎体压缩骨折的系统评价[J].中医正骨,2019,31(03):28.
LI Zhaoyong,YANG Shaofeng,ZHANG Chenyang.Oral application of Bushen Huoxue Fang(补肾活血方)combined with percutaneous vertebral augmentation for treatment of osteoporotic vertebral compression fractures:a systematic review[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(07):28.
[18]杨磊,崔宏勋,饶耀剑,等.弯角穿刺椎体成形装置辅助下单侧穿刺经皮椎体成形术治疗骨质疏松性椎体压缩骨折[J].中医正骨,2020,32(01):64.
[19]陈晨,安忠诚,张英健,等.椎体强化术后残留腰背痛的研究进展[J].中医正骨,2020,32(05):26.
[20]刘锐,龚德飞,班正涛,等.经皮椎体成形术治疗骨质疏松性椎体压缩骨折术中骨水泥渗漏的危险因素分析[J].中医正骨,2022,34(11):14.
LIU Rui,GONG Defei,BAN Zhengtao,et al.Risk factors for bone cement leakage during percutaneous vertebroplasty treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(07):14.